Doc­tors with­out Bor­ders asks J&J not to en­force sec­ondary patents for TB drug af­ter gener­ic deal with non­prof­it

Doc­tors with­out Bor­ders crit­i­cized a deal be­tween John­son & John­son and the Stop TB Part­ner­ship that al­lows the Swiss non­prof­it to man­u­fac­ture and sup­ply gener­ic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER